Mi L J, Mahl E, Chaung W, Boorstein R J
Department of Pathology, Sackler Institute of Graduate Biomedical Sciences, New York University Medical Center, New York, USA.
Mutat Res. 1997 Mar 21;374(2):287-95. doi: 10.1016/s0027-5107(96)00247-3.
V79mut1 cells are resistant to the toxic effects of 5-hydroxymethyl-2'-deoxyuridine (hmdUrd) and are deficient in the DNA repair enzyme hydroxymethyluracil-DNA glycosylase (hmUDG). We have therefore proposed that the toxicity of hmdUrd results from the repair of the lesion from DNA. In order to clarify the biological role of hmUDG, we have determined whether the repair-deficient cells showed resistance or sensitivity to the toxic or mutagenic effects of other DNA-damaging agents. Cells were exposed to hmdUrd, ionizing or ultraviolet radiation, to the alkylating agent MNNG, and to oxidative stress produced by hypoxanthine/xanthine oxidase, glucose/glucose oxidase, nitric oxide donor SNAP, or to H2O2. The V79mut1 cells did not show increased mutagenesis in response to hmdUrd. Relative to the V79 parent cells, the V79mut1 cells were not markedly altered in sensitivity to oxidizing agents and ionizing radiation (which produce hmdUra in DNA). The repair-deficient cells wee equally sensitive as the parent V79 cells to DNA damage induced by ultraviolet radiation or by MNNG. No significant differences were seen between the parent and the repair-deficient cells in terms of synthesis of poly(ADP-ribose) in response to damage or in their sensitization to 3-aminobenzamide. Thus, the loss of the 5-hydroxymethyluracil (hmUra)-DNA glycosylase activity in mammalian cells in culture confers no obvious deleterious effect on cell survival or mutagenicity in response to a wide range of DNA damage. These studies indicate that the major lesion known to be repaired by hmUra-DNA glycosylase, an hmUra residue replacing thymine, is produced in cells only in small quantities as the result of exposure to common DNA-damaging agents. These results raise the possibility that hmUra-DNA glycosylase may have evolved to respond to other lesions than hmUra residues formed from the oxidation of thymine.
V79mut1细胞对5-羟甲基-2'-脱氧尿苷(hmdUrd)的毒性作用具有抗性,并且缺乏DNA修复酶羟甲基尿嘧啶-DNA糖基化酶(hmUDG)。因此,我们提出hmdUrd的毒性是由DNA损伤的修复引起的。为了阐明hmUDG的生物学作用,我们确定了修复缺陷型细胞对其他DNA损伤剂的毒性或诱变作用是表现出抗性还是敏感性。细胞分别暴露于hmdUrd、电离辐射或紫外线辐射、烷化剂MNNG以及由次黄嘌呤/黄嘌呤氧化酶、葡萄糖/葡萄糖氧化酶、一氧化氮供体SNAP产生的氧化应激或H2O2。V79mut1细胞对hmdUrd的诱变反应并未增加。相对于V79亲本细胞,V79mut1细胞对氧化剂和电离辐射(在DNA中产生hmdUra)的敏感性没有明显改变。修复缺陷型细胞对紫外线辐射或MNNG诱导的DNA损伤与亲本V79细胞同样敏感。在对损伤的反应中,亲本细胞和修复缺陷型细胞在聚(ADP-核糖)合成或对3-氨基苯甲酰胺的敏感性方面没有显著差异。因此,培养的哺乳动物细胞中5-羟甲基尿嘧啶(hmUra)-DNA糖基化酶活性的丧失对细胞存活或对多种DNA损伤的诱变性没有明显的有害影响。这些研究表明,已知由hmUra-DNA糖基化酶修复的主要损伤,即一个hmUra残基取代胸腺嘧啶,仅在细胞暴露于常见DNA损伤剂后少量产生。这些结果增加了一种可能性,即hmUra-DNA糖基化酶可能已经进化以应对除胸腺嘧啶氧化形成的hmUra残基之外的其他损伤。